tiprankstipranks
Zentek (ZTEKF)
OTHER OTC:ZTEKF

Zentek (ZTEKF) Price & Analysis

73 Followers

ZTEKF Stock Chart & Stats

$0.60
$0.04(6.88%)
At close: 4:00 PM EDT
$0.60
$0.04(6.88%)

Bulls Say, Bears Say

Bulls Say
Low Financial LeverageModest leverage and a meaningful equity base reduce refinancing and solvency pressure while giving Zentek some capacity to continue investing in technology commercialization. This financial cushion is a durable offset to operating weakness, although it does not eliminate the need to control losses.
Government Commercialization TractionA federal standing offer provides external validation for ZenGUARD HVAC filters and creates a defined route to potential government sales through 2027. While the stated maximum is modest, the arrangement can support customer credibility and future adoption of Zentek’s materials technology.
Expanding Intellectual Property PipelineA new provisional patent filing strengthens Zentek’s intellectual-property pipeline and broadens its potential application set beyond existing filtration and coating efforts. Protectable technology can support future licensing, partnerships, and differentiated commercialization if technical validation and market adoption follow.
Bears Say
Very Small, Declining RevenueExtremely low and declining revenue indicates that Zentek has not yet converted its research and product portfolio into repeatable commercial scale. Until sales growth becomes sustained, fixed development costs will remain difficult to absorb and the business will have limited internal funding capacity.
Persistent UnprofitabilityRepeated losses and deeply negative operating results show that Zentek’s current business model has not reached economic breakeven. The brief period of positive annual gross profit in 2025 did not establish stable margins, leaving profitability dependent on stronger commercialization and revenue growth.
Ongoing Cash BurnConsistently negative operating and free cash flow means current activities consume cash rather than fund themselves. Continued burn can reduce the company’s financial cushion over time and may constrain investment in product development or require additional financing if commercialization does not accelerate.

ZTEKF FAQ

What was Zentek’s price range in the past 12 months?
Zentek lowest stock price was $0.37 and its highest was $1.10 in the past 12 months.
    What is Zentek’s market cap?
    Zentek’s market cap is $64.87M.
      When is Zentek’s upcoming earnings report date?
      Zentek’s upcoming earnings report date is Nov 16, 2026 which is in 64 days.
        How were Zentek’s earnings last quarter?
        Currently, no data Available
        Is Zentek overvalued?
        According to Wall Street analysts Zentek’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Zentek pay dividends?
          Zentek does not currently pay dividends.
          What is Zentek’s EPS estimate?
          Zentek’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Zentek have?
          Zentek has 126,619,530 shares outstanding.
            What happened to Zentek’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Zentek?
            Currently, no hedge funds are holding shares in ZTEKF
            What is the TipRanks Smart Score and how is it calculated?
            Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

              Zentek Stock Smart Score

              Company Description

              Zentek

              Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compound. In addition, it develops synthesize graphene, graphene oxide, and graphene quantum dots for applications of graphene. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Thunder Bay, Canada.
              Similar Stocks
              Company
              Price & Change
              Follow
              Arch Biopartners
              BioMark Diagnostics
              Medexus Pharmaceuticals Inc
              Sona Nanotech Inc

              Ownership Overview

              1.58%0.04%2.11%96.27%
              2.11% Other Institutional Investors
              96.27% Public Companies and
              Individual Investors
              Popular Stocks